Albemarle (ALB.PR.A) | Financial Analysis & Statements

Albemarle Corporation | Mid-cap | Basic Materials

$35.68

1.19%

Albemarle vs Linde plc Albemarle vs Sherwin-Williams Albemarle vs Eastman Chemical Albemarle vs Albemarle Albemarle vs NewMarket Albemarle vs S&P 500 | Market

Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 5.4B

Gross Profit 62.5M 1.16%

Operating Income -642.2M -11.94%

Net Income -1.1B -21.12%

Balance Sheet Metrics

Total Assets 16.6B

Total Liabilities 6.4B

Shareholders Equity 10.2B

Debt to Equity 0.63

Cash Flow Metrics

Operating Cash Flow 1.2B

Free Cash Flow -983.7M

Revenue & Profitability Trend

Interactive Financial Charts Not Available

This page uses interactive financial charts and dynamic data visualization tools that require JavaScript. For detailed financial analysis:

Available Financial Data:

Income statements (annual and quarterly)
Balance sheets with asset and liability details
Cash flow statements and free cash flow analysis
Key financial ratios and performance metrics
Peer comparison and industry benchmarking

All financial data is displayed in accessible table format below. Use the table headers and structure to analyze trends and compare metrics across different periods.

Albemarle Income Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Revenue	5.4B	9.6B	7.3B	3.3B	3.1B
Cost of Goods Sold	5.3B	8.4B	4.2B	2.3B	2.1B
Gross Profit	62.5M	1.2B	3.1B	998.0M	994.9M
Operating Expenses	704.8M	995.7M	596.1M	495.5M	489.0M
Operating Income	-642.2M	190.2M	2.5B	502.5M	505.8M
Pre-tax Income	-1.8B	246.7M	2.4B	133.6M	373.5M
Income Tax	87.1M	430.3M	390.6M	29.4M	54.4M
Net Income	-1.1B	1.7B	2.8B	199.9M	446.6M
EPS (Diluted)	-	-	-	-	-

Income Statement Trend

Albemarle Balance Sheet From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Assets
Current Assets	3.8B	5.2B	5.2B	2.0B	2.2B
Non-Current Assets	12.8B	13.1B	10.3B	9.0B	8.2B
Total Assets	16.6B	18.3B	15.5B	11.0B	10.5B
Liabilities
Current Liabilities	2.0B	3.6B	2.7B	1.9B	1.8B
Non-Current Liabilities	4.4B	5.0B	4.5B	3.3B	4.2B
Total Liabilities	6.4B	8.6B	7.3B	5.2B	6.0B
Equity
Total Shareholders Equity	10.2B	9.7B	8.2B	5.8B	4.5B

Balance Sheet Composition

Albemarle Cash Flow Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Operating Activities
Net Income	-1.1B	1.7B	2.8B	199.9M	446.6M
Operating Cash Flow	1.2B	975.9M	2.1B	609.7M	1.0B
Investing Activities
Capital Expenditures	29.1M	0	0	0	0
Investing Cash Flow	28.8M	-427.4M	-161.7M	280.6M	-13.1M
Financing Activities
Dividends Paid	-311.3M	-187.2M	-184.4M	-177.9M	-161.8M
Financing Cash Flow	1.2B	623.7M	609.1M	31.8M	136.8M
Free Cash Flow	-983.7M	-824.0M	646.2M	-609.4M	-51.6M

Cash Flow Trend

Albemarle Key Financial Ratios

Valuation Ratios

Price to Book 0.54

Price to Sales 0.79

Profitability Ratios

Profit Margin -22.39%

Operating Margin 1.90%

Return on Equity -9.99%

Return on Assets -1.51%

Financial Health

Current Ratio 2.11

Debt to Equity 35.76

Beta 1.61

Per Share Data

Book Value per Share $66.24

Revenue per Share $43.33

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
alb.pr.a	4.2B	-	0.54	-9.99%	-22.39%	35.76
Linde plc	216.0B	33.33	5.69	17.01%	20.02%	60.56
Sherwin-Williams	86.3B	32.56	20.80	70.22%	11.63%	329.97
Eastman Chemical	9.3B	10.22	1.58	16.03%	9.85%	86.00
Albemarle	7.9B	33.52	0.99	-9.99%	-22.39%	35.76
NewMarket	6.9B	14.45	4.51	35.98%	17.22%	70.09

Financial data is updated regularly. All figures are in the company's reporting currency.